Infant Pacifier
#602POWDER FOR USE IN TREATING TOOTH SURFACES
#603APPLICATION OF CALCIUM ALUMINATE IN PRE-MIXED DENTAL FILLING MATERIALS, PRE-MIXED DENTAL FILLING MATERIALS AND THEIR PREPARATION METHODS
#604SOLID CARE AND/OR MAKEUP COMPOSITION
#605METHOD OF PRODUCING SOLID PARTICLE
#606Oral Care Compositions
#607ANHYDROUS COMPOSITION THAT STABILIZES POORLY SOLUBLE INGREDIENTS AND PROVIDES EXCELLENT FEELING OF USE
#608Anhydrous Urea Emulsions with a Retinoid Agent
#609SUNSCREEN COMPOUNDS AND FORMULATIONS
#610Solid Cleansing Compositions
#611ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN
#612HAIR COSMETIC COMPOSITION
#613COMPOSITION COMPRISING A SURFACE-REACTED CALCIUM CARBONATE AND A TANNIN
#614COSMETIC COMPOSITION COMPRISING LUTEIN AND A POLYSACCHARIDE
#615Yeast-Based Masks for Improved Skin, Hair and Scalp Health
#616USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE
#617TREATING KNEE JOINT PAIN BY INJECTING RESINIFERATOXIN AT ULTRA LOW DOSES
#618POLYNUCLEOTIDES ENCODING ANTIBODIES WHICH BIND THE EC3 DOMAIN OF CADHERIN-6 (CDH6) AND POSSESS INTERNALIZATION ABILITY
#619COMPOSITIONS AND METHODS FOR DRUG INSTILLATION INTO THE URINARY BLADDER
#620Intestinal-targeted sustained-release of polyphenols and preparation method and application thereof
#621OROMUCOSAL THERAPEUTIC SYSTEM CONTAINING AN ADHESIVE LAYER
#622ALKALINE INTRAORAL FORMULATIONS
#623ALKALINE INTRAORAL PRODUCTS
#624DRUG DELIVERY SYSTEM COMPRISING A REFLUX INHIBITOR FOR THE APPLICATION TO ESOPHAGEAL MUCOUS MEMBRANES
#625PROTECTION OF BIOLOGICAL SPECIES FROM DEGRADATION
#626SYSTEMS AND METHODS FOR ACCELERATED HYDROLYSIS OF POLYSACCHARIDE-BASED HYDROGELS
#627ETHANOLIC RESINIFERATOXIN CONCENTRATE
#628DELIVERY OF AGENTS USING METASTABLE LIPOSOMES
#629COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#630PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#631METHOD AND COMPOSITION FOR TREATING PULMONARY FIBROSIS
#632NOVEL COMPOSITION
#633SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS
#634SOLID EXTENDED-RELEASE COMPOSITION COMPRISING BRADYKININ B2-RECEPTOR ANTAGONISTS
#635PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR
#636ANTIFIBROTIC COMPOSITION
#637MICROCAPSULE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN PREVENTING AND/OR TREATING DAMAGE TO SALIVARY GLANDS CAUSED BY RADIATION THERAPY
#638METHOD FOR PRODUCING DELIVERY VESICLES
#639BIOLOGICAL MATERIAL FOR DELIVERING SPECIFIC CELL-TARGETED METABOLIC SYSTEM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#640COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS
#641METHOD FOR PRODUCING ALBUMIN-BOUND TAXANE NANOPARTICLES WITH IMPROVED STABILITY IN MAINTAINING PARTICLE SIZE DISTRIBUTION
#642PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF
#643COMPOSITION FOR USE IN THE TREATMENT OF URINARY OR FAECAL INCONTINENCE
#644WATER-BASED FORMULATION OF DISCREET LIQUID PATCH FOR THE PAIN-FREE TREATMENT OF COLD SORES
#6452,4-Dinitrophenol Formulations and Methods Using Same
#646HOMOVANILLYL ALCOHOL (HVA), HVA ISOMER, METHODS OF MAKING COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS USING SUCH COMPOUNDS
#647ESTROGENIC COMPOUNDS AND METHODS OF USE
#648SKELETAL MUSCLE ENHANCER
#649SYNERGIC AND STABLE PHARMACEUTICAL COMPOSITION OF AN NSAID AND AN OPIOID ANALGESIC FOR PAIN AND INFLAMMATION
#650INDANE-, INDENE-, AZAINDANE-, AND AZAINDENE-AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS
#651SALT OF A PHARMACEUTICAL COMPOUND
#652Treatment of nasal cavity inflammation and mucus hypersecretion.
#653USE OF Galectin-1 INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS
#654EXTENDED RELEASE MIDODRINE HYDROCHLORIDE COMPOSITIONS AND METHODS OF USE
#655NASAL FORMULATIONS OF METOCLOPRAMIDE
#656USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS
#657PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
#658AMPK ACTIVATOR, MOTOR FUNCTION IMPROVING AGENT, MUSCULAR ENDURANCE IMPROVING AGENT, AND MUSCLE ATROPHY PREVENTING AGENT
#659TRANEXAMIC CLASS ARGININE AND HISTIDINE MIMICS AS THERAPEUTIC AGENTS
#660COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS DISEASES
#661COMPOSITIONS FOR USE
#662COMPOSITIONS FOR USE
#663Triester Compounds And Methods Of Use Thereof
#664FLUORINATED PHENYLAMINO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#665METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER
#666COMBINATION THERAPIES FOR THE TREATMENT OF VIRAL INFECTIONS
#667LYOPHILIZED RESINIFERATOXIN
#668ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#669ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#670PHARMACEUTICAL COMBINATION CONTAINING CAPSID PROTEIN INHIBITOR AND REVERSE TRANSCRIPTASE INHIBITOR
#671COMPOSITIONS COMPRISING ATICAPRANT
#672METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS DISPLAYING NORMAL COGNITIVE PERFORMANCE
#673N-DESMETHYL RUBOXISTAURIN AS A KINASE INHIBITOR
#674COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS
#675PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL
#676COMPOSITIONS AND METHODS FOR INHIBITION OF ITO AS TREATMENT FOR THE J WAVE SYNDROMES AND HYPOTHERMIA
#677COMPOSITIONS OF RAPAMYCIN AND THEIR USE IN THE TREATMENT OF MICROCYSTIC LYMPHATIC MALFORMATION
#678COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING
#679METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS
#680METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#681FORMULATIONS WITH ENHANCED SN-38 SOLUBILITY AND ORAL ABSORPTION
#6824-AMINOPYRIDINE (4-AP) AND BONE MORPHOGENETIC PROTEIN 2 (BMP-2)
#683METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS
#684METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
#685METHODS AND COMPOSITIONS FOR TREATING AGITATION
#686PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER
#687PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#688BILASTINE COMPOSITION FOR ONCE-DAILY PARENTERAL ADMINISTRATION
#689(2S)-1-[4-(3,4-DICHLOROPHENYL)PIPERIDIN-1-YL]-3-[2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)BENZO[B]FURAN-4-YLOXY] PROPAN-2-OL OR ITS METABOLITE FOR TREATING ANXIETY DISORDERS
#690METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
#691COMPOSITION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE
#692METHODS OF TREATING SJÖGREN-LARSSEN SYNDROME
#693COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES
#694USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME
#695COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USE
#696SINGLE NUCLEOTIDE POLYMORPHIC ALLELES OF HUMAN DP-2 GENE FOR DETECTION OF SUSCEPTIBILITY TO HAIR GROWTH INHIBITION BY PGD2
#697COMBINATION DOSAGE FORMS AND ADMINISTRATION THEREOF
#698MORPHINE FORMULATIONS
#699COMBINATION THERAPY FOR TREATING CANCER
#700PROCESS FOR MAKING A KRAS G12C INHIBITOR
#701FORMULATION AND MANUFACTURING PROCESS OF LIQUID FORMULATION OF RILPIVIRINE
#702COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR MODULATOR
#703ALLOSTERIC INHIBITOR COMPOUNDS FOR OVERCOMING CANCER RESISTANCE
#704CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
#705Apoptosis Inhibitors
#706HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUNDS AND THEIR APPLICATIONS
#707PYRAZINAMIDE COMPOUNDS
#708USE OF HEMATOPOIETIC CELL KINASE (HCK) INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS
#709BIOSENSOR AND USES THEREOF
#710ANTI-CANCER COMBINATION THERAPY
#711FORMULATIONS OF VILOXAZINE
#712METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
#713Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors
#714METHODS OF USING ATR INHIBITORS
#715Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors
#716THERAPIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
#717COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME
#718CRYSTALLINE FORM OF (R)-1-(3-(3-(4-AMINOPYRIMIDIN-2-YL)-5-CHLOROPHENYL)MORPHOLINO)PROP-2-EN-1-ONE
#719METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT
#720METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
#721Benzodiazepine Pyrazolo Carboxamides as N-protein Inhibitors
#722CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING BRONCHIECTASIS
#723FULVESTRANT FORMULATIONS
#724PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR DELIVERY OF AN ANDROGENIC AGENT AND AN AROMATASE INHIBITOR WITH SUSTAINED MULTI-PHASIC RELEASE PROFILES AND METHODS OF USE
#725C25 R AND S ISOMERS OF AMINOSTEROLS AND METHODS OF MAKING AND USING THE SAME
#726CALCITRIOL OR CALCITRIOL ANALOGUES FOR TREATING PERIPERHAL NEUROPATHIC PAIN DISORDERS
#727METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME
#728COMPOSITIONS FOR DELIVERY OF CANNABINOIDS
#729MANAGEMENT OF SKIN AILMENTS
#730METHOD FOR THE SYNTHESIS OF EVOC PROBES
#731METHOD AND COMPOSITION FOR CONTROLLING ACNE USING RHAMNOLIPIDS
#732REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS
#733COMPOSITION FOR PREVENTION OR TREATMENT OF MULTIPLE MYELOMA COMPRISING NOVEL TETRACYCLIC TRITERPENE COMPOUND AS ACTIVE INGREDIENT
#734ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS
#735Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions
#736ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#737COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING GPAM
#738COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS
#739OPHTHALMIC COMPOSITION
#740Methods of administering safe colon cleansing compositions
#741METHODS AND COMPOSITIONS FOR TREATING HEART CONDITIONS
#742ANTI-CANCER FORMULATION COMPRISING SODIUM PENTABORATE, CURCUMIN AND PIPERINE FOR USE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA
#743COMBINATIONS CONTAINING OXYLANTHANUM CARBONATE FOR TREATING HYPERPHOSPHATEMIA
#744METHOD FOR MAKING COPPER-SILVER PHOSPHATE OXIDE NANOPARTICLES FROM COPPER OXIDE
#745BROAD SPECTRUM ANTISEPTIC NANO EMULSION BASED ON A COMBINATION OF IONIC LIQUID AND COPPER NANOCLUSTERS
#746TRUNCATED DOMAIN IV EGFR AND USES THEREOF
#747COMPOUNDS TO INHIBIT YTHDF2, T HELPER CELLS LACKING EXPRESSION OF YTHDF2, AND METHODS TO TREAT CANCER
#748MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS
#749VAGINAL CARE COMPOSITIONS AND METHODS OF IMPROVING VAGINAL HEALTH
#750METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION
#751GENERATING AND UTILIZING ADULT HEPATOCYTE ORGANOIDS
#752NATURAL MATRIX MIXTURE FOR THE TREATMENT OF BONE FRAGILITY
#753COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN
#754COMBINATION DRUG FOR TREATING MALIGNANT TUMOR
#755AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
#756SYNBIOTIC COMPOSITIONS FOR METABOLIC MANAGEMENT ESPECIALLY GLUCOSE METABOLISM MANAGEMENT AND MODULATION OF SATIETY HORMONE LEVELS
#757MICROBIAL COMMUNITIES THAT INHIBIT CLOSTRIDIOIDES DIFFICILE AND METHODS OF USING SAME
#758Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof
#759COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS
#760TREATING ORTHOPEDIC INJURY WITH A VECTOR DRIVING EXPRESSION OF ACID CERAMIDASE
#761THERAPEUTIC COMPOSITIONS AND METHODS
#762EXTRACT OF MELASTOMA DODECANDRUM LOUR. FOR TREATING ULCERATIVE COLITIS, PREPARATION METHOD THEREFOR AND USE THEREOF
#763BURDOCK SEED OIL-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME
#764COMPOSITION AND METHODS OF TREATMENT FOR SKIN HEALTH AND SLEEP QUALITY USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION
#765STABILIZED OMEGA-3 OPHTHALMIC COMPOSITIONS
#766PHARMACOLOGICAL, HEALTH OR DIETARY PREPARATION FOR TREATING HYPOSALIVATION
#767DISTINCT CD8+ T CELL PROGRAMMING IN THE TUMOR MICROENVIRONMENT CONTRIBUTES TO SEX BIAS IN CANCER
#768A METHOD OF TREATING OR PREVENTING SEPSIS
#769METHODS OF TREATING FIBROSIS AND ARRHYTHMIA WITH A NEUREGULIN-1 FUSION PROTEIN
#770METHODS OF CONTROLLING BODY WEIGHT AND/OR ENERGY EXPENDITURE
#771Insulin Derivative
#772LONG-ACTING PARATHYROID HORMONE
#773TREATMENT OF ARGINASE 1 DEFICIENCY
#774METHODS FOR TREATMENT OF DISEASES
#775COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS
#776IDENTIFICATION OF G. PARASUIS IMMUNOGENIC PROTEINS AND SUBUNIT VACCINE COMPRISING SUCH
#777METHODS AND RELATED ASPECTS FOR INCREASING ANTIGENIC INSERTION SITES ON A RECOMBINANT IMMUNE COMPLEX PLATFORM
#778RNA VACCINE LIPID NANOPARTICLES
#779RECOMBINANT FUSION PROTEIN DERIVED FROM HR REGION OF S2 PROTEIN OF SARS-COV-2 AND APPLICATION OF RECOMBINANT FUSION PROTEIN
#780IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT
#781RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT
#782SARS-COV-2 RNA VACCINE COMPOSITIONS AND METHODS OF USE
#783ALPHAVIRUS REPLICON ENCODING CHIMERIC SARS-COV-2 RECEPTOR BINDING DOMAINS
#784HUMAN CYTOMEGALOVIRUS VACCINE
#785Human Cytomegalovirus Immunogenic Composition
#786ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME
#787CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM
#788COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1 INHIBITORS
#789MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
#790THE COMBINATION OF MACROPHAGE-DIRECTED IMMUNOTHERAPY AND TARGETED AGENTS FOR TREATMENT OF CANCER
#791ENHANCED IMMUNE CELL THERAPY
#792COMPOSITIONS AND METHODS FOR EFFICIENT AND STABLE GENETIC MODIFICATION OF EUKARYOTIC CELLS
#793CELLULAR THERAPY
#794METHODS FOR ACTIVATION AND EXPANSION OF ENGINEERED NATURAL KILLER CELLS AND COMBINATIONS WITH ANTIBODIES
#795CELLS HAVING SOLID TUMOR TARGETING BACKBONE AND USE THEREOF
#796COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS
#797NEOANTIGENS AND USES THEREOF
#798ANTI-CD3 ANTIBODY FORMULATIONS
#799METAL-ORGANIC FRAMEWORKS AS SOLID SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS
#800METHODS OF TREATING OR PREVENTING STENT THROMBOSIS
#801COLLAGEN MATRICES OF VARYING CHARGE AND CROSS-LINKING DENSITY
#802Prodrugs Activated by Reduction in the Cytosol
#803NOVEL-PEPTIDE-BASED ANTICANCER IMMUNOTHERAPEUTIC AGENT
#804BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2)
#805INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES
#806Designing Antisense Oligonucleotide Delivery Peptides by Interpretable Machine Learning
#807PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS
#808PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD AND USE THEREOF
#809BIFUNCTIONAL DEGRADERS OF GALACTOSE-DEFICIENT IMMUNOGLOBULINS
#810TSP1 INHIBITOR
#811TRANSFERRIN-BASED LYSOSOME TARGETING DEGRADERS
#812METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY
#813PRACTICAL GLYCAN ENGINEERING METHOD FOR THE PREPARATION OF HOMOGENOUS ANTIBODY CONJUGATES
#814HYDROGEL PRODRUG FOR TREATMENT
#815HYDROGEL PRODRUG FOR TREATMENT
#816PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS
#817NANOPARTICLES COMPRISING AT LEAST ONE METAL SALT AND AT LEAST ONE PEPTIDE
#818LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS
#819AAV CAPSID VARIANTS AND USES THEREOF
#820TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS
#821GENE EDITING TO IMPROVE JOINT FUNCTION
#822GENE THERAPY FOR THE TREATMENT OF COGNITIVE DISORDERS
#823DESIGN AND CONSTRUCTION OF EVOLUTIONARY-GUIDED "SELECTION GENE DRIVE" THERAPY
#824METHOD OF PRODUCTION AND USE OF PREPARATION COMPRISING CODON-OPTIMIZED HUMAN COAGULATION FACTOR IX (hFIXco)-TRANSDUCED HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS (tr-HUCMSCs)
#825GENE EDITING METHODS FOR TREATING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY
#826MODULATION OF NEURAL PATHWAYS
#827METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES
#828AAV CAPSIDS THAT ENABLE CNS-WIDE GENE DELIVERY THROUGH INTERACTIONS WITH THE TRANSFERRIN RECEPTOR
#829Compositions and Methods for Treating Striatonigral Degeneration
#830ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER
#831BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF
#832GENE THERAPY FOR HAPLOINSUFFICIENCY
#833BASE EDITING METHODS AND COMPOSITIONS FOR TREATING TRIPLET REPEAT DISORDERS
#834OXIDATIVE NANOPARTICLES FOR USE IN THE TREATMENT OF DISEASES AND MEDICAL CONDITIONS
#835PROBES FOR CELLULAR SENESCENCE
#836Metallophore-Radionuclide Complex as Nuclear Imaging Contrast Agents
#837COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
#838Diffusing Alpha-Emitter Radiation Therapy for Lung Cancer
#839SYSTEM AND METHOD FOR WASHING CONTAINERS FOR PHARMACEUTICAL USE
#840FLUID STERILIZATION DEVICE
#841UV DISINFECTION PLATFORM
#842Vehicle Sanitation System
#843A wireless disinfecting apparatus using ozone
#844Enhanced Dispenser Control
#845Enhanced Dispenser Control
#846FRAGRANCE LANYARD
#847BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE
#848VASCULAR EMBOLIC AGENT, METHOD FOR PREPARING SAME AND USE THEREOF
#849BONE REGENERATIVE AGENT AND METHOD OF USING SAME
#850Anionic Citrate-Based Biomaterials
#851EXTRACELLULAR MATRIX SHEET STRUCTURES
#852ACELLULAR DERMAL TISSUE PREPARED USING SUPERCRITICAL FLUID EXTRACTION, AND USE THEREOF
#853ANCHORED CELL CONSTRUCT CULTURE
#854SYSTEM AND METHODS FOR SOFT-TISSUE AUGMENTATION
#855DISSOLVABLE CALCIUM ALGINATE MICROFIBERS PRODUCED VIA IMMERSED MICROFLUIDIC SPINNING TOWARDS FABRICATION OF EMBEDDED MICROFLUIDIC NETWORKS
#856BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION
#857OXIME-BASED CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS
#8583D PRINTED ARTIFICIAL BILE DUCTS AND MANUFACTURING METHOD THEREOF
#859UNIAXIALLY-ALIGNED NANOFIBER SCAFFOLDS AND METHODS FOR PRODUCING AND USING SAME
#860DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES
#861MEDICAL WIRE MATERIAL AND GUIDE WIRE
#862PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONIST
#863THREE-WAY CONNECTING ASSEMBLY AND WEARABLE BREAST PUMP
#864PERITONEAL DIALYSIS SYSTEM AND METHOD HAVING INTRAPERITONEAL PRESSURE SENSING
#865DISPOSABLE CASSETTE CONDITIONING SYSTEM AND METHOD
#866METHOD, DEVICE, EQUIPMENT, AND MEDIUM FOR EVALUATING PATIENT ECMO OPERATION STATUS
#867ENDOVASCULAR IMPLANTS AND DEVICES AND METHODS FOR CREATING A PERCUTANEOUS ARTERIOVENOUS FISTULA
#868APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY
#869SYSTEM AND METHODS AND PORTABLE BASE FOR BOWEL IRRIGATION
#870DRUG INFUSION DEVICE WITH INTEGRATED POWER SUPPLY AND ARTIFICIAL PANCREAS
#871PUMP WITH EVACUATED DRIVER
#872SYSTEM AND METHOD FOR MONITORING ACCURACY OF A SYRINGE PUMP
#873Intuitive Total Intravenous Anesthesia Infusion System and Method of Operation
#874INJECTION DEVICE, INJECTION ASSEMBLY AND MONITORING DEVICE
#875CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM
#876SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM
#877MULTI-CARTRIDGE INJECTOR AND METHODS OF MAKING AND USING SAME
#878AUTOMATIC INJECTION DEVICE WITH ROTATION SENSOR
#879CARTRIDGE ASSEMBLY AND FIXING MEMBER
#880DISPENSING DEVICE INCORPORATING DIAPHRAGM
#881MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS FOR DELIVERY OF TREATMENT AGENT(S)
#882Universal Dosage Verification System and Method for Medical Syringe
#883AUTOINJECTOR WITH FINGER GRIP
#884INJECTOR WITH REDUCED BREAK LOOSE FORCE
#885INJECTION ENDPOINT MONITORING SYSTEM AND METHOD
#886Automatic feedback mechanism for a medicament delivery device
#887FREEZE-DRY POWDER INJECTOR RESTORING DEVICE
#888Multi-Chamber Syringe with Pressure Valve for Sequential Delivery of Fluids and Methods of Use
#889Medicament Delivery Device
#890METHOD OF PROVIDING A PERSONAL DRUG INJECTION SYSTEM
#891FLUID MANAGEMENT SYSTEMS AND METHODS
#892AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAME
#893Oil Diffuser Device
#894INHALATION DEVICE
#895OXYGEN CONCENTRATOR SYSTEM
#896METHODS AND APPARATUS FOR VENTILATORY TREATMENT OF RESPIRATORY DISORDERS
#897DISPOSABLE ANGLE-ADJUSTABLE VISUAL BRONCHIAL BLOCKER
#898SYSTEMS AND METHODS FOR ASSISTING PATIENT AIRWAY MANAGEMENT
#899PATIENT INTERFACE
#900BIFURCATED CANNULA DEVICE